TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 56 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,000 | -61.1% | 50,000 | -91.9% | 0.00% | – |
| Q2 2023 | $406,474 | +106866.8% | 614,938 | +28.9% | 0.00% | – |
| Q1 2023 | $380 | -56.5% | 477,045 | +23.4% | 0.00% | – |
| Q4 2022 | $874 | -99.7% | 386,589 | +121.7% | 0.00% | – |
| Q3 2022 | $337,000 | -58.1% | 174,378 | -19.3% | 0.00% | – |
| Q2 2022 | $804,000 | +14.9% | 216,168 | +260.0% | 0.00% | – |
| Q4 2021 | $700,000 | +9.5% | 60,049 | +99.1% | 0.00% | – |
| Q2 2021 | $639,000 | +49.0% | 30,165 | +42.8% | 0.00% | – |
| Q1 2021 | $429,000 | -16.7% | 21,125 | +8.9% | 0.00% | – |
| Q4 2020 | $515,000 | -86.7% | 19,400 | -88.8% | 0.00% | -100.0% |
| Q3 2020 | $3,881,000 | – | 173,257 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Investment Advisors, LLC | 10,000 | $17,700 | 0.00% |